ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

RFPs Available, Contract Awards, Sole Source Negotiations

June 25, 1976

In Brief: Money Bill Awaits President’s Decisions; M.D. Anderson To Dedicate New Faculties

September 24, 1976

COG’s Peter Adamson Has A Conversation With The Cancer Letter

March 15, 2013

Seven Seats Open Up On NCAB

January 17, 1986

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

April 26, 2013

Reduced-Fat Diet May Cut Risk Of Breast Cancer Recurrence.

December 22, 2006